Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults
Status:
Recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
This is a double-blind, randomized, vehicle controlled Phase 3 study to evaluate the efficacy
and safety of topical tapinarof cream, 1% compared to vehicle control cream in pediatric and
adult subjects with atopic dermatitis.